These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8608195)

  • 1. Measurements of haptoglobin by the reaction with concanavalin A in sera of patients with ovarian tumours.
    Katnik I; Jadach J; Kmieciak K; Gerber J; Dobryszycka W
    Eur J Clin Chem Clin Biochem; 1995 Oct; 33(10):727-32. PubMed ID: 8608195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating haptoglobin is an independent prognostic factor in the sera of patients with epithelial ovarian cancer.
    Zhao C; Annamalai L; Guo C; Kothandaraman N; Koh SC; Zhang H; Biswas A; Choolani M
    Neoplasia; 2007 Jan; 9(1):1-7. PubMed ID: 17325738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum haptoglobin, CA 125 and interleukin 6 levels in malignant and non-malignant tumors of the ovary.
    Dobryszycka W; Katnik-Prastowska I; Gerber J; Lemańska K; Utko K; Rozdolski K
    Arch Immunol Ther Exp (Warsz); 1999; 47(4):229-36. PubMed ID: 10483871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haptoglobin concentration in serum and other body fluids measured by comparison of its reactivity with hemoglobin and concanavalin A.
    Katnik I; Jadach J
    Arch Immunol Ther Exp (Warsz); 1996; 44(1):45-50. PubMed ID: 8874769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haptoglobin and proteinase inhibitors in the blood serum of women with inflammatory, benign and neoplastic lesions of the ovary.
    Warwas M; Gerber J; Pietkiewicz A
    Neoplasma; 1986; 33(1):79-84. PubMed ID: 2421174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haptoglobin typing and quantitation in normal Chinese females and gynecologic cancer patients.
    Ko TM; Su BT; May SY; Huang SC; Wen HK; Ouyang PC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1980 Jun; 13(2):149-57. PubMed ID: 7449531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical usefulness of serum acute-phase reactants in patients with ovarian tumors.
    Warwas M; Dobryszycka W; Gerber J; Pietkiewicz A
    Neoplasma; 1981; 28(4):485-90. PubMed ID: 7290269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haptoglobin types in ovarian tumors.
    Dobryszycka W; Warwas M
    Neoplasma; 1983; 30(2):169-72. PubMed ID: 6843722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated levels of abnormally-fucosylated haptoglobins in cancer sera.
    Thompson S; Turner GA
    Br J Cancer; 1987 Nov; 56(5):605-10. PubMed ID: 3426924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of concanavalin A-enzyme immunosorbent assay for glycated haptoglobin using polyclonal and monoclonal antibodies.
    Katnik I; Dobryszycka W
    J Immunoassay; 1992; 13(2):145-62. PubMed ID: 1430237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parallel changes in the blood levels of abnormally-fucosylated haptoglobin and alpha 1,3 fucosyltransferase in relationship to tumour burden: more evidence for a disturbance of fucose metabolism in cancer.
    Thompson S; Cantwell BM; Matta KL; Turner GA
    Cancer Lett; 1992 Aug; 65(2):115-21. PubMed ID: 1511415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ascites levels of haptoglobin in patients with ovarian cancer.
    Elg SA; Carson LF; Fowler JM; Twiggs LB; Moradi MM; Ramakrishnan S
    Cancer; 1993 Jun; 71(12):3938-41. PubMed ID: 8389656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Affino-immunoelectrophoresis of haptoglobin with wheat germ agglutinin. Diagnostic significance in ovarian carcinoma.
    Katnik I; Gerber J; Dobryszycka W
    Arch Immunol Ther Exp (Warsz); 1987; 35(4):547-52. PubMed ID: 3439855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haptoglobin phenotype and epithelial ovarian cancer.
    Mandato VD; Magnani E; Abrate M; Casali B; Nicoli D; Farnetti E; Formisano D; Pirillo D; Ciarlini G; De Iaco P; Strada I; Zamagni C; La Sala GB
    Anticancer Res; 2012 Oct; 32(10):4353-8. PubMed ID: 23060558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer.
    Ahmed N; Oliva KT; Barker G; Hoffmann P; Reeve S; Smith IA; Quinn MA; Rice GE
    Proteomics; 2005 Nov; 5(17):4625-36. PubMed ID: 16220531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methods to quantitate human haptoglobin by complexation with hemoglobin.
    Cerda S; Oh SK
    J Immunol Methods; 1990 Nov; 134(1):51-9. PubMed ID: 2230149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-2 receptor and ovarian cancer.
    Owens OJ; Taggart C; Wilson R; Walker JJ; McKillop JH; Kennedy JH
    Br J Cancer; 1993 Aug; 68(2):364-7. PubMed ID: 8347492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes of serum proteins in patients with malignant gynaecological tumours.
    Pulay T; Csömör S; Kovács I; Szarka G; Somos P
    Acta Chir Hung; 1988; 29(4):305-14. PubMed ID: 3266407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrins and haptoglobin: Molecules overexpressed in ovarian cancer.
    Villegas-Pineda JC; Garibay-Cerdenares OL; Hernández-Ramírez VI; Gallardo-Rincón D; Cantú de León D; Pérez-Montiel-Gómez MD; Talamás-Rohana P
    Pathol Res Pract; 2015 Dec; 211(12):973-81. PubMed ID: 26549463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum haptoglobin in patients with ovarian malignancies.
    Mueller WK; Handschumacher R; Wade ME
    Obstet Gynecol; 1971 Sep; 38(3):427-35. PubMed ID: 4999312
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.